We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Nanomedicine Presents Unique Challenges to IRBs
Nanomedicine Presents Unique Challenges to IRBs
December 14, 2011
Nanomedicine is an exciting new field that offers great promise, but much about this cutting-edge technology is unknown, which argues for a precautionary approach by institutional review boards (IRB) and researchers to protect all parties involved in nanomedicine trials, a National Institutes of Health- (NIH) funded panel says.